CUBT OTC
Curative Biotechnology, Inc.
1W: -16.3%
1M: +4.0%
3M: -22.6%
YTD: +25.1%
1Y: -27.4%
3Y: -48.4%
5Y: -94.5%
$0.93
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-110.2% ▼
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$1M
-104.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$37K
-1525.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$5M | -$5M | -$4M | -$4M |
| Depreciation & Amort. | $5K | $7K | $854K | $90K | $92K |
| Stock-Based Comp. | $4M | $3M | $279K | $228K | $0 |
| Change in Working Capital | $109K | $549K | $3M | -$47K | $828K |
| Other Non-Cash Items | $31K | $125K | -$95K | $3M | $2M |
| Operating Cash Flow | -$190K | -$2M | -$2M | -$487K | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$34K | -$21K | -$77K | -$14K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$34K | -$21K | -$77K | -$14K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $385K | $60K | $983K | $35K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $502K | -$98K | -$79K | $86K |
| Financing Cash Flow | $385K | $2M | $1M | $498K | $986K |
| Net Change in Cash | $161K | $510K | -$612K | -$2K | -$37K |
| Cash End of Period | $161K | $670K | $59K | $56K | $20K |
| Free Cash Flow | -$224K | -$2M | -$2M | -$501K | -$1M |